Immunic, Inc.
IMUX
$12.32
$0.131.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.24M | 23.56M | 21.25M | 21.00M | 19.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 117.88M | 109.64M | 103.23M | 105.53M | 105.27M |
| Operating Income | -117.88M | -109.64M | -103.23M | -105.53M | -105.27M |
| Income Before Tax | -111.57M | -104.29M | -97.17M | -103.05M | -101.84M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -111.57 | -104.29 | -97.17 | -103.05 | -101.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -111.57M | -104.29M | -97.17M | -103.05M | -101.84M |
| EBIT | -117.88M | -109.64M | -103.23M | -105.53M | -105.27M |
| EBITDA | -117.73M | -109.48M | -103.06M | -105.37M | -105.10M |
| EPS Basic | -4.20 | -5.42 | -6.86 | -8.36 | -9.45 |
| Normalized Basic EPS | -2.57 | -3.33 | -4.23 | -5.23 | -5.91 |
| EPS Diluted | -4.20 | -5.42 | -6.86 | -8.36 | -9.45 |
| Normalized Diluted EPS | -2.57 | -3.33 | -4.23 | -5.23 | -5.91 |
| Average Basic Shares Outstanding | 111.47M | 82.18M | 62.17M | 52.81M | 43.55M |
| Average Diluted Shares Outstanding | 111.47M | 82.18M | 62.17M | 52.81M | 43.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |